Sanctuary Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
53,624
+522
+1% +$16.6K 0.01% 993
2026
Q1
$1.4M Buy
53,102
+1,494
+3% +$43.8K 0.01% 1142
2025
Q4
$1.5M Sell
51,608
-3,988
-7% -$120K 0.01% 1088
2025
Q3
$1.54M Buy
55,596
+5,603
+11% +$142K 0.01% 1039
2025
Q2
$1.22M Sell
49,993
-31,144
-38% -$682K 0.01% 1106
2025
Q1
$1.68M Buy
81,137
+64,119
+377% +$1.61M 0.01% 853
2024
Q4
$464K Buy
+17,018
New +$419K ﹤0.01% 1726
2024
Q3
Sell
-9,590
Closed -$222K 2417
2024
Q2
$222K Buy
+9,590
New +$242K ﹤0.01% 2120

Other funds holding ARKG

Sanctuary Advisors's ARKG Position: Q2 2026 in Review

Sanctuary Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 0.98% in Q2 2026, buying an estimated $16.6K and bringing the position to 53,624 shares worth $2.26M. The position accounts for 0.01% of the portfolio, ranked #993.

Sanctuary Advisors first reported a position in ARKG in Q2 2024 and has held it in 8 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Sanctuary Advisors held 53,624 shares of ARK Genomic Revolution ETF worth $2.26M as of Q2 2026.
  • Sanctuary Advisors bought 522 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $16.6K.
  • ARK Genomic Revolution ETF made up 0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #993 holding.
  • Sanctuary Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2024 and has held it in 8 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.